Ekso Bionics Inc.

NASDAQ: EKSO · Real-Time Price · USD
3.17
-0.02 (-0.63%)
At close: Aug 15, 2025, 12:24 PM

Ekso Bionics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.49M 8.64M 20.52M 40.41M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
433K 392K 231K 164K
Receivables
7.24M 5.64M 4.63M 4.66M
Inventory
4.57M 5.05M 5.19M 2.24M
Other Current Assets
541K 875K 700K 485K
Total Current Assets
18.84M 20.21M 31.04M 47.8M
Property-Plant & Equipment
2.37M 3M 3.99M 1.21M
Goodwill & Intangibles
5.01M 5.32M 5.65M n/a
Total Long-Term Assets
7.81M 8.71M 9.87M 1.37M
Total Assets
26.65M 28.92M 40.9M 49.17M
Account Payables
1.55M 1.85M 3.15M 3.11M
Deferred Revenue
1.96M 1.99M 1.12M 1.22M
Short-Term Debt
1.25M 1.25M 2.65M 229K
Other Current Liabilities
2.35M 606K 188K 110K
Total Current Liabilities
7.54M 8.12M 9.2M 6.86M
Long-Term Debt
3.85M 4.83M 4.85M 1.99M
Other Long-Term Liabilities
2.55M 471K -713K 1.62M
Total Long-Term Liabilities
6.41M 8.2M 6.26M 5.09M
Total Liabilities
13.95M 16.31M 15.46M 11.95M
Total Debt
5.98M 7.17M 7.5M 2.22M
Common Stock
22K 15K 13K 13K
Retained Earnings
-250.47M -239.15M -223.95M -208.87M
Comprehensive Income
957K 156K 563K -17K
Shareholders Equity
12.71M 12.61M 25.44M 37.22M
Total Investments
n/a n/a n/a n/a